<DOC>
	<DOCNO>NCT01942655</DOCNO>
	<brief_summary>Progressive HIV HIV infection seem related preferential loss CD4+ T lymphocytes , especially Th17+ , within mucosal intestinal lymphoid tissue , intestinal mucosal damage bacterial product translocation , correlate hyperactivation immune system , therefore CD4+ T cell loss prognosis . The objective project investigate correlation IL12/IL-23 imbalance bacterial product translocation , study polarization , infection depletion intestinal Th17 ex vivo . The investigator test effect neutralize anti-IL23 antibody direct p40 , less classically , anti- IL-23 p19 .</brief_summary>
	<brief_title>IL-23/IL-12 Imbalance T Lymphocyte Polarization HIV Infection</brief_title>
	<detailed_description>Th17 lymphocytes fight bacterial fungal intestinal infection . Under combined antiretroviral therapy , even plasma viral load undetectable , hyperactivation persist , induce localize replication reservoir . In human , Th17 lymphocyte differentiation expansion depend IL-23 . The investigator first uncover imbalance respective production IL-12 IL-23 response Lipopolysaccharide ( LPS ) HIV-1 infected patient . IL-23 receptor implicate pathogenesis chronic inflammatory bowel disease ( IBD ) like Crohn 's disease , mucosa alter Th17 cell , induce bacterial product translocation . IBD efficiently treat antibody direct Tumor Necrosis Factor-α ( TNF-α ) , current clinical trial , p40 chain share IL-12 IL-23 . Unfortunately , antibody inhibit also IL-12 . IL-12 crucial mycobacteria , opportunistic HIV-infected patient . Antibodies direct p19 chain IL-23 would inhibit Th17 activation specifically . The investigator collect blood recto-colic biopsy 15 healthy donor , 15 HIV-infected patient viral load high 5000 copies/ml 15 patient evolutive IBD , establish parallel two disease . The objective project study correlation IL12/IL-23 imbalance bacterial product translocation , investigate polarization , infection depletion intestinal Th17 ex vivo . Investigators test effect neutralize anti-IL23 antibody direct p40 , less classically , anti- IL-23 p19 . If correlation validate , investigator propose anti-IL-23 neutralizing treatment allow Th17 intestinal integrity come back balance , therefore break vicious cycle immune system hyperactivation draw bacterial translocation .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>Age high 18 Able give write consent Rectocolic biopsies prescribe patient care Covered French Health Insurance System ( Social Security ) ( 15 HIV patient document detectable HIV viral load past 6 month , 15 HIV negative patient evolutive IBD , 15 HIV negative patient without evolutive IBD ) Absence coverage French Health insurance system ( Social Security ) Known progressive malignancy Indeterminate colitis Known autoimmune disease IBD Current chemotherapy radiotherapy Vulnerable population ( child , pregnant woman , person legal guardianship , deprive freedom judicial administrative decision )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>Chronic inflammatory bowel disease</keyword>
	<keyword>Reservoirs</keyword>
	<keyword>IL-17</keyword>
	<keyword>IL-23</keyword>
	<keyword>Intestinal biopsy</keyword>
</DOC>